Certification Underscores Lionbridge's Market-Leading Translation Management Program for Life Sciences Organizations Worldwide
WALTHAM, Mass., March 10 /PRNewswire-FirstCall/ -- Lionbridge (Nasdaq: LIOX) today announced that it recently received ISO 13485:2003 certification which verifies quality management systems for medical device companies. This certification expands Lionbridge's dedicated Life Sciences program and enhances the Company's translation management platform to adhere to the rigorous compliance requirements of its medical device clients. Lionbridge was awarded this certification as part of its Life Sciences Center of Excellence initiative, which provides specialized translation services to leading medical device companies, pharmaceutical companies, and contract research organizations around the world.
"This independent certification reflects our proven level of excellence in delivering translation services for medical device and life sciences organizations. As the market leader in translation, Lionbridge is committed to providing the highest levels of quality and service to ensure our clients meet and exceed their customers' expectations while adhering to strict regulatory compliance regulations," said Henri Broekmate, General Manager, Global Language and Content, Lionbridge. "Our clients can take advantage of our superior capabilities in translation and other services with the confidence of knowing our processes comply with the demanding requirements of ISO 13485."
ISO 13485:2003 is an internationally recognized quality standard that outlines particular quality management system requirements tailored to the manufacture of medical devices. ISO 13485:2003 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer requirements and regulatory requirements applicable to medical devices and related services. The primary objective of ISO 13485:2003 is to facilitate harmonized medical device regulatory requirements for quality management systems. All requirements of ISO 13485:2003 are specific to organizations providing medical devices, regardless of the type or size of the organization.
Lionbridge's recent ISO 13485:2003 certification complements its existing ISO 9001-2000 certification.
Lionbridge Technologies, Inc. (Nasdaq: LIOX) is a leading provider of translation, development and testing services with FY 2008 revenue of $461 million. Lionbridge combines global resources with proven program management methodologies to serve as an outsource partner throughout a client's product and content lifecycle -- from development to translation, testing and maintenance. Global organizations rely on Lionbridge services to increase international market share, speed adoption of global products and content, and enhance their return on enterprise applications and IT system investments. Based in Waltham, Mass., Lionbridge maintains solution centers in 26 countries and provides services under the Lionbridge(R) and VeriTest(R) brands. To learn more, visit http://www.lionbridge.com.
Contact: Sara Buda 781-434-6190 firstname.lastname@example.org
|SOURCE Lionbridge Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved